In this section
@article{Hodgson:2021:10.2807/1560-7917.es.2021.26.20.2100428,
author = {Hodgson, D and Flasche, S and Jit, M and Kucharski, AJ},
doi = {10.2807/1560-7917.es.2021.26.20.2100428},
journal = {Eurosurveillance},
pages = {2--8},
title = {The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant},
url = {http://dx.doi.org/10.2807/1560-7917.es.2021.26.20.2100428},
volume = {26},
year = {2021}
}
TY - JOUR
AB - Initial reports of vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease (COVID-19), have suggested a substantial reduction of the risk of infection [1]. Nevertheless, with the emergence of more transmissible variants such as B.1.1.7 [2], how large-scale immunisation programmes against SARS-CoV-2 will perform is currently unclear. This study assesses the potential of COVID-19 vaccination to generate herd immunity and takes into account vaccine effectiveness, naturally-acquired immunity and achievable vaccination coverage (depending on the population age structure), as well as two transmissibility scenarios ((i) with pre-B.1.1.7, and (ii) with exclusively B.1.1.7 variants).
AU - Hodgson,D
AU - Flasche,S
AU - Jit,M
AU - Kucharski,AJ
DO - 10.2807/1560-7917.es.2021.26.20.2100428
EP - 8
PY - 2021///
SN - 1560-7917
SP - 2
TI - The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant
T2 - Eurosurveillance
UR - http://dx.doi.org/10.2807/1560-7917.es.2021.26.20.2100428
VL - 26
ER -
For any enquiries related to the MRC Centre please contact:
Scientific Manager
Susannah Fisher
mrc.gida@imperial.ac.uk
External Relationships and Communications Manager
Dr Sabine van Elsland
s.van-elsland@imperial.ac.uk